Actavia Life Sciences Inc (RASP)
0.004
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Actavia Life Sciences Total Liabilities (Quarterly): 2.230M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.230M |
| December 31, 2023 | 2.130M |
| September 30, 2023 | 2.052M |
| June 30, 2023 | 2.012M |
| March 31, 2023 | 1.923M |
| December 31, 2022 | 1.870M |
| September 30, 2022 | 1.774M |
| June 30, 2022 | 1.858M |
| March 31, 2022 | 2.174M |
| December 31, 2021 | 2.537M |
| September 30, 2021 | 2.798M |
| June 30, 2021 | 3.016M |
| March 31, 2021 | 2.897M |
| December 31, 2020 | 2.832M |
| September 30, 2020 | 2.708M |
| June 30, 2020 | 2.627M |
| March 31, 2020 | 2.665M |
| December 31, 2019 | 2.483M |
| September 30, 2019 | 2.408M |
| June 30, 2019 | 2.466M |
| March 31, 2019 | 2.378M |
| Date | Value |
|---|---|
| December 31, 2018 | 2.331M |
| September 30, 2018 | 2.120M |
| June 30, 2018 | 1.736M |
| March 31, 2018 | 1.412M |
| December 31, 2017 | 1.319M |
| June 30, 2017 | 1.635M |
| March 31, 2017 | 1.528M |
| December 31, 2016 | 4.20M |
| September 30, 2016 | 0.8499M |
| June 30, 2016 | 0.0726M |
| March 31, 2016 | 0.0186M |
| December 31, 2015 | 0.0167M |
| September 30, 2015 | 0.0141M |
| June 30, 2015 | 0.0105M |
| March 31, 2015 | 0.01M |
| December 31, 2014 | 0.0026M |
| September 30, 2014 | 0.0016M |
| June 30, 2014 | 0.001M |
| March 31, 2014 | 0.0006M |
| December 31, 2013 | 0.0013M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.774M
Minimum
Sep 2022
3.016M
Maximum
Jun 2021
2.368M
Average
2.408M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0486M |
| Shareholders Equity (Quarterly) | -2.182M |